Our Work

Gynesonics Sonata Treatment for Fibroids

Breaking down barriers using peer to peer advocacy 

We activated early adopters to launch Sonata, a new non-surgical intrauterine fibroid treatment into the UK.  Fibroids are a common condition affecting around 1 in 3 women and the majority of treatments available involve surgical intervention.  The Sonata System from US-based Gynesonics, integrates imaging guidance (ultrasound) and therapy (radiofrequency) into one mobile unit, and offers a new incisionless alternative to treat female patients with symptomatic fibroids.

More Creative

And so, ‘Treat Smarter with Sonata’ was born.  A campaign theme that quickly communicated the health economic advantage of the new treatment as well as the smarter technology behind the treatment.

More Value for Money

Working with early adopter clinicians during COVID we produced film clips extolling the advantages of the new treatment.  With detailed briefings, ring lights and expert coaching they delivered film content that could be stitched together into social content which talked to the new treatment’s advantages.

Share this:

Ready for some fresh ideas?

Get In Touch